Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

(2010) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Colorectal Cancer Due to Deficiency in DNA Mismatch Repair Function

(2009) Andrew M. Bellizzi et al.   ADVANCES IN ANATOMIC PATHOLOGY

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

(2009) Seung Tae Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Clinical implications of microsatellite instability in sporadic colon cancers

(2009) Frank A Sinicrope et al.   CURRENT OPINION IN ONCOLOGY

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

(2009) Monica M. Bertagnolli et al.   JOURNAL OF CLINICAL ONCOLOGY

Current Status of Chemotherapy for Advanced Colorectal Cancer in Japan

(2008) Yasuhide Yamada   Clinical Colorectal Cancer

The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status

(2008) Rodrigo Jover et al.   EUROPEAN JOURNAL OF CANCER